ArticleMolecular cancer therapeutics2017

NKG2D Ligand-Targeted Bispecific T-Cell Engagers Lead to Robust Antitumor Activity against Diverse Human Tumors.

Claire Godbersen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.